Tauriga Sciences Inc (TAUG)

[Johnny_C]

227,291,853 and 107,039,107 outstanding at December 31, 2020 and March 31, 2020, respectively

Kind of looks like VistaGen, 75 million shares to 225 million shares (in 6 months) but PPS rose from .60 to $2.75

TAUG PPS rose from .03 to .14 during the time frame you cited.

227,291,853 and 107,039,107 outstanding at December 31, 2020 and March 31, 2020, respectively

Market Cap rose from $3.5 million to $36 million, that is kind of important.

227,291,853 and 107,039,107 outstanding at December 31, 2020 and March 31, 2020, respectively

Vistagen, Serendipty and AEGEA investments alone worth more than the March 31st market cap. Now add in the CBD gum and other retail portfolio and the potential of a drug trial for the multi billion dollar nausea market

227,291,853 and 107,039,107 outstanding at December 31, 2020 and March 31, 2020, respectively

During the year direct sale approvals to major chains like CVS and walmart, the first CBD product to Alibaba. Direct sales authorizations cut out the middle man. Just a guess, but as regualatory issues continue to be removed I would take an educated guess that these TAUG products will be sold in many of these retailers.

227,291,853 and 107,039,107 outstanding at December 31, 2020 and March 31, 2020, respectively

What would you value the CBD gum product line portfolio at? $20 million. $40 million $100 million. Hard to say for sure but it is a great product in a very hot market.

What would you value the potential of a CBD gum trial for nausea, it is an annual multi billion dollar market. One CBD drug was recently bought for $7 billion dollars. At some point the FDA should clear this for trial. I doubt it has been cheap getting this far.

I bet Seth would tell that not everything went perfect, like any business there were mistakes. But rather than quit he caught up on 13 filings after the the auditor that committed and tried to conceal malpractice was ordered to return the documents needed to get the filings done. The Company has maintained reporting compliance (expensive) and a solid brand has been developed, investors have decent trading liquidity and the potential of a moving a pharma grade study along is huge.

What is the company worth is anyone's guess, it is not zero and it is not $1 billion. It is intersting how VTGN went from a $40 mil market cap to over a $600 market cap in 6 months with no approval in sight for at least a year and a half. Blink went from a $50 million dollar market to a $2 billion dollar market cap in less than 2 years and on less than $4 million in sales. ZOM looked like it was done 6 months ago and now has a $2 billion dollar market cap.

I like the products and think the long term value is in the pharma potential, if the retail pays the bills that is a plus. There is no salesforce and I think if one develops retail sales will further improve. Seems like the company has made lots of progress despite the pandemic and the huge setback by New York changing the laws right after Tauri Gum launched there.


Just saying, there is more to the story than simply posting the share increase. One thing I think we will agree on, hopefully no more convertible notes